Obesity hypoventilation syndrome (OHS) is defined as chronic daytime hypercapnia in obese patients (those with a BMI of > 30kg/m2) with a daytime PaCO2 of over 45 mmHg, after ruling out any other causes of hypoventilation.1
As many as 90% of patients with OHS also suffer from obstructive sleep apnoea (OSA).2
OHS is defined as chronic daytime hypercapnia in obese patients after ruling out any other causes of hypoventilation.
Recommended treatment options for OHS include controlled weight loss and noninvasive ventilation.
Adhering to therapy is critical for patients receiving noninvasive ventilation.
Learn about the positive outcomes for OHS patients being treated with NIV.
Educate patients on the importance of timely equipment replacement and how critical it is to the success of their sleep apnoea therapy.